Matuzumab is a humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, competitively blocking natural ligand binding and inhibiting receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation. The directory classifies it as a discontinued API with a biotechnology source/manufacturing origin. Other names for this substance include DTXSID301053205, EMD 72000 and matuzumabum. Its PubChem SID is 505806396.
Matuzumab
| CAS No | 339186-68-4 |
|---|---|
| Molecular Formula | N/A |
| Molecular Weight | ~150 kDa |
| Synonyms | N/A |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Matuzumab is a humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, competitively blocking natural ligand binding and inhibiting receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation.
The listed CAS number is 339186-68-4.
The listed molecular formula is N/A.
The listed molecular weight is ~150 kDa.
N/A.
The source lists DTXSID301053205, EMD 72000 and matuzumabum.